From the previous discussion, it can be seen that the heat of metamorphism mainly comes from magma. The formation of UHP is closely related to both the stress formed by arch tectonics and the thermal ...

A decision on apitegromab is due by Sept. 22, with Scholar Rock planning to make it available in the U.S. this year, if it is approved.

Two Vietnamese college students, Doan Nguyen Han Thinh and Pham To Lam Phon, were welcomed to Arkansas with a reception at ...

BISMARCK, N.D. (KFYR) - For the second straight year, Bismarck State College (BSC) was selected for the Metallica Scholars ...

With a market cap of $3.1 billion, Scholar Rock Holding Corporation appears fairly valued for now. Click here to read an ...

Scholar Rock (NASDAQ:SRRK), a late-stage biopharmaceutical company specializing in therapies for serious neuromuscular and rare diseases, released its second quarter 2025 earnings on August 6, 2025.

Scholar Rock Reports Second Quarter 2025 Financial Results and Highlights Business Progress FDA accepted the apitegromab BLA under priority review with a PDUFA target action of September 22, 2025 ...

Norman Finkelstein, a political scientist and activist known for his fiery on-air criticisms of Israel’s ongoing genocide in Gaza, is giving a talk in Little Rock this month.

View 湖石小犬 Dog and scholars rock by Ren Bonian on artnet. Browse upcoming and past auction lots by Ren Bonian.

Strategic collaborations and late-stage clinical assets position Scholar Rock to compete in high-value therapeutic markets. Foolish take Scholar Rock is a clinical-stage biotech.

Scholar Rock Holding Corporation (NASDAQ:SRRK – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Scholar Rock in a ...